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Abstract - Recently it was observed that several trace elements, including manganese (Mn), can affect the cardiovascular 
system and have been implicated in certain cardiovascular disease mechanisms. However, to date the effects of Mn on the 
vascular system, such as in the control of blood flow and blood pressure, are not completely understood. The main objec-
tive of the present study was to determine the effects of a 45-day exposure to two different doses of Mn, on blood pressure 
values of male Wistar rats. Our results show a significant time effect (p<0.001, ANOVA, repeated measures) on blood 
pressure during the 45 days of chronic Mn treatment with two doses of Mn (3 mg/kg/day; 10 mg/kg/day). Additionally, we 
observed significant differences in blood pressure, especially on days 2 (p<0.001), 9 (p<0.05), 24 (p<0.05), 28 (p<0.01) and 
43 (p<0.05). Further studies are necessary in order to establish the mechanism and relevance of Mn.
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INTRODUCTION
Manganese (Mn) is a multifunctional trace element 
and well-known neurotoxic agent that participates 
in many fundamental processes in the cell (Mergler 
et al., 1997, Klos et al., 2006, Vukojević et al., 2009, 
Vezer et al., 2007, Shukakidze et al., 2003, Ponzoni et 
al., 2000).
In our previous studies, published in this jour-
nal, we reported that chronic manganese exposure 
of Wistar rats led to behavioral alterations consist-
ing of working memory deficiencies in the Y-maze 
task, and anxiety-like behavior in the elevated plus 
maze, but no motor disturbances as tested by the 
number of arm entries in the Y-maze (Hogas et al., 
2011).
Recently it was demonstrated that several trace 
elements, including manganese, affect the cardio-
vascular system; they have been implicated in some 
cardiovascular disease mechanisms (Yan et al., 1998, 
2001), by participating in cell signal transduction 
pathways,  which  further  affect  the  biomechanical 
properties of the vessels (Kalea et al., 2005). Aside 
from the putative mechanisms of manganese action 
on vascular tone and blood pressure, this multifunc-
tional  trace  element  could  mimic  the  superoxide 
dismutase  (SOD)  enzyme  systems  (Kasten  et  al., 
1994, Gray and Carmichael, 1992) and thereby po-
tentiate the activity of nitric oxide (NO) on vascular 
tone (Bild et al., 2013, Kasten et al., 1994). The ef-
fects of Mn on the vascular system, such as the con-
trol of blood flow and blood pressure, coagulation, 
platelet  aggregation,  vessel  permeability,  wound 1196 IONELA LACRAMIOARA SERBAN ET AL.
healing and angiogenesis, are still largely unknown 
(reviewed by: Klimis-Tavantzis et al. (Taylor et al., 
1997, Klimis-Tavantzis et al., 1993, Yang et al., 1998 
a,b), with many gaps in our knowledge on the mech-
anistic processes and signaling pathways (Kalea et 
al., 2005).
For this reason, the main objective of the present 
study was to determine the effects of a 45-day expo-
sure to two different doses of Mn on blood pressure 
values in male Wistar rats.
MATERIALS AND METHODS
Animals
Male  Wistar  rats  (n=12),  weighing  approximately 
180-250 g at the beginning of the experiment were 
used. The animals were housed in a temperature- and 
light-controlled room (23 ± 2ºC; a 12-h cycle start-
ing at 08:00 h) and were fed and allowed to drink 
water ad libitum. The rats were treated in accordance 
with the guidelines of animal bioethics from the Act 
on Animal Experimentation and Animal Health and 
Welfare Act from Romania; all procedures complied 
with the European Communities Council Directive 
of 24 November, 1986 (86/609/EEC). This study was 
approved by the local Ethic Committee and efforts 
were made to minimize animal suffering and to re-
duce the number of animals used. 
Drug treatment
Manganese (Sigma, USA) was injected intraperito-
neally (i.p.) to two separate groups of rats in doses 
of 3 mg/kg/day and 10 mg/kg/day for 45 consecu-
tive days. A sample size of n=6 for each experimen-
tal group was used. Blood pressure measurements 
were performed with an electronic system (HUGO 
SACHS D 7806) especially designed to non-invasive-
ly measure the blood pressure in rats by the tail-cuff 
method.
Measurements  (all  sampling  was  done  three 
times on average) were performed two times before 
starting the Mn administration (day 1 and 2) and 
eight times (on days 4, 9, 16, 20, 24, 28, 32 and 43) 
during the 45 days of manganese administration.
Data Analysis
The  total  values  of  blood  pressure  measurements 
were statistically analyzed by two-way ANOVA re-
peated measures for dose effect (3 mg/kg/day vs. 10 
mg/kg/day) and time effect (days of measurements). 
In addition, the differences for each day were statis-
tically analyzed by Student’s t-test (two-tailed, un-
paired). All results are expressed as mean±SEM. P 
<0.05 was considered as statistically significant. The 
analyses were performed using the SPSS program 
(version 17.0).
RESULTS
When  we  first  analyzed  the  total  values  of  blood 
pressure,  we  observed  no  statistical  differences 
(ANOVA, repeated measures; treatment effect, p = 
0.8; days effect, p <0.001) between the values of the 
blood pressure measurements during the entire pe-
riod of treatment (both before and after starting the 
Mn treatment) between the two different doses we 
chose to use in our experiment (3 mg/kg/day and 10 
mg/kg/day) (Fig.e 1). However, as can be seen from 
the p value for the time effect (number of days), a 
significant effect exists between the doses used in our 
experiment.
Additionally, when we used the Student’s t-test, 
two–tailed and unpaired (considering that we had 
only two groups to compare), we also observed sig-
nificant differences in the values of the blood pres-
sure measurements, especially on days 2 (p < 0.001), 
9 (p < 0.05), 24 (p < 0.05), 28 (p < 0.01) and 43 (p < 
0.05) (Fig. 1).
DISCUSSION
The effects of manganese exposure on blood pres-
sure and vascular contraction have been studied in a 
very few instances. Kasten et al. (1994) showed that 
the administration of Mn decreased blood pressure. 
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L-arginine, which leads to the idea that Mn increases 
the duration of NO half-life, probably through some 
mechanisms that involving the stimulation of SOD 
that in turn increases the effects of NO on the vas-
cular domain. These aspects are also explained by 
the observation that different species of SOD contain 
manganese, copper or zinc in its active sites (Ciobica 
et al., 2012). In addition, Jamieson et al. (1983) dem-
onstrated that manganese reduced blood pressure, as 
studied on guinea-pig isolated trachea. These effects 
were explained as the result of interaction between 
Mn and ion channels, as well as neurotransmitters 
and specific receptors (Kalea et al., 2005).
Additionally, in a study involving approximately 
700 children patients from South Africa it was dem-
onstrated (by regression analysis), that the cardio-
vascular parameters of hypertensive subjects signifi-
cantly correlated with manganese (along with vita-
min E, B12, A or iron) levels. In addition, the study 
showed that the dietary intake of these nutrients was 
way below the necessary reference needed (Schutte 
et al., 2003). It was also reported that dietary manga-
nese influences the vascular contraction mechanisms 
in the thoracic aorta of rats. Kalea et al. (2005) dem-
onstrated in Sprague-Dawley rats that were either 
fed with a deficit of Mn or supplemented with Mn, 
that  dietary  Mn  influences  the  receptor  signaling 
pathways and contractile characteristics of vascular 
smooth muscle cells by a mechanism mainly involv-
ing the α1 adrenergic receptor. Interestingly enough, 
the maximum contractile force was obtained in the 
case of the Mn-adequate group of rats, while the low-
est was reported for the Mn-supplemented group; the 
vessel reactivity reached its highest values in the case 
of the Mn-deficient group. This confirms that despite 
the existence of some important studies in this area of 
research, the current knowledge regarding the blood 
pressure and vascular contraction mechanisms are 
quite limited and waiting to be further established.
Our results describe a significant time effect on 
blood pressure during 45 days of chronic Mn treat-
ment (3 mg/kg/day; 10 mg/kg/day). Significant dif-
Fig. 1. Blood-pressure values during the 45 days of Mn administration in rat.1198 IONELA LACRAMIOARA SERBAN ET AL.
ferences in blood pressure were observed on days 2, 
9, 24, 28 and 43.
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